Procter & Gamble Health Reappoints S. Madhavan Independent Director

Board Decision

At its meeting held on May 26, 2026, the Board of Directors approved the reappointment of Mr. S. Madhavan as Independent Director of the Company. This decision was made based on the recommendation of the Nomination & Remuneration Committee.

Appointment Terms

• Effective Date: November 15, 2026
• Term: Five years (from November 15, 2026 to November 14, 2031)
• Condition: Subject to approval of the shareholders of the Company
• Reason: Completion of first tenure

Compliance Confirmations

The company confirms that:

• Mr. Madhavan meets the criteria of independence laid down in Section 149 of the Companies Act, 2013 and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
• He is not debarred or disqualified from holding the office of a Director by any order from SEBI/MCA or any statutory authority
• He does not hold any shares in the Company
• He is not disqualified from holding the office of a Director pursuant to Section 164 of the Companies Act, 2013

Director Relationships

None of the Directors of the Company are related to Mr. S. Madhavan.